Higher Dose Daunorubicin Appears Beneficial in Patients Harbouring A Flt3-Itd Mutation: Updated Results of the UK Ncri Aml17 Trial
Authors
Russell, NHills, R
Cavenagh, J
Kjeldsen L
McMullin, M
Cahalin, P
Dennis, Michael
Friis, L
Grech, A
Milligan, D
Clark, R
Burnett, A
Affiliation
Department of Haematology, Nottingham University NHS Trust, NottinghamIssue Date
2016